Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Effects of Low-Dose Doxycycline on Oral Bone Loss

ClinicalTrials.gov ID: NCT00066027

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00066027. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Low-Dose Doxycycline Effects on Osteopenic Bone Loss

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this clinical trial is to determine whether low-dose doxycycline can reduce alveolar bone density loss in postmenopausal osteopenic women with periodontitis and not on hormone replacement therapy (i.e., estrogen deficient).

Study identification

NCT ID
NCT00066027
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Nebraska
Other
Enrollment
128 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
45 Years to 70 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1, 2002 (Actual)
Primary completion
Oct 1, 2005 (Actual)
Completion
Oct 1, 2005 (Actual)
Last update posted
Sep 6, 2023

2002 – 2005

United States locations

U.S. sites
2
U.S. states
2
U.S. cities
2
Facility City State ZIP Site status
University of Nebraska Medical Center, College of Dentistry Lincoln Nebraska 68583-0740 —
Department of Oral Biology and Pathology Stony Brook New York 11794-8702 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00066027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 6, 2023 · Synced Nov 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.